JP2531868B2 - モダフィニルの新規使用 - Google Patents

モダフィニルの新規使用

Info

Publication number
JP2531868B2
JP2531868B2 JP3143267A JP14326791A JP2531868B2 JP 2531868 B2 JP2531868 B2 JP 2531868B2 JP 3143267 A JP3143267 A JP 3143267A JP 14326791 A JP14326791 A JP 14326791A JP 2531868 B2 JP2531868 B2 JP 2531868B2
Authority
JP
Japan
Prior art keywords
modafinil
mptp
dose
new use
dopamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP3143267A
Other languages
English (en)
Japanese (ja)
Other versions
JPH04230214A (ja
Inventor
ラフォン ルイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RABO ERU RAFUON SA
Original Assignee
RABO ERU RAFUON SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RABO ERU RAFUON SA filed Critical RABO ERU RAFUON SA
Publication of JPH04230214A publication Critical patent/JPH04230214A/ja
Application granted granted Critical
Publication of JP2531868B2 publication Critical patent/JP2531868B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Networks Using Active Elements (AREA)
  • Steroid Compounds (AREA)
JP3143267A 1990-06-14 1991-06-14 モダフィニルの新規使用 Expired - Lifetime JP2531868B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9007442 1990-06-14
FR9007442A FR2663225B1 (fr) 1990-06-14 1990-06-14 Nouvelle utilisation du modafinil.

Publications (2)

Publication Number Publication Date
JPH04230214A JPH04230214A (ja) 1992-08-19
JP2531868B2 true JP2531868B2 (ja) 1996-09-04

Family

ID=9397614

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3143267A Expired - Lifetime JP2531868B2 (ja) 1990-06-14 1991-06-14 モダフィニルの新規使用

Country Status (12)

Country Link
US (1) US5180745A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0462004B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2531868B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100190454B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE127341T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU655769B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69112717T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0462004T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2663225B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK1007415A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU215590B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW206916B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950010400B1 (ko) * 1990-08-16 1995-09-16 삼성전자주식회사 김치냉장고의 발효 및 저장제어방법
FR2684875B1 (fr) * 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases
FR2697162B1 (fr) * 1992-10-23 1995-01-13 Lafon Labor Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux.
FR2706767B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1993-06-22 1995-09-08 Lafon Labor
FR2708201B1 (fr) * 1993-06-30 1995-10-20 Lafon Labor Utilisation de dérivés d'acétamide pour la fabrication de médicaments.
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
KR980010274A (ko) * 1996-07-23 1998-04-30 오상수 열전소자를 이용한 식품저장고
US6346548B1 (en) * 1999-08-16 2002-02-12 Cephalon, Inc. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
US6455588B1 (en) 1999-08-20 2002-09-24 Cephalon, Inc. Compositions including modafinil for treatment of eating disorders and for appetite stimulation
KR100350444B1 (ko) * 2000-02-22 2002-08-28 만도공조 주식회사 복합형 김치저장고
US6492396B2 (en) * 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
US6489363B2 (en) * 2000-10-11 2002-12-03 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US6919378B2 (en) * 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
PL215226B1 (pl) * 2000-10-11 2013-11-29 Cephalon Kompozycja farmaceutyczna zawierajaca zwiazek modafinilu, sposób jej wytwarzania oraz jej zastosowanie
US7141555B2 (en) 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US7704975B2 (en) * 2000-12-19 2010-04-27 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
ATE357228T1 (de) * 2001-05-25 2007-04-15 Cephalon Inc Feste pharmazeutische formulierung enthaltend modafinil
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
IL153098A0 (en) * 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
FR2849029B1 (fr) * 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
JP2006518754A (ja) * 2003-02-24 2006-08-17 マリンクロッド・インコーポレイテッド ベンズヒドリルチオアセトアミドの改良製法
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
EP1586560A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituted arylmethanesulfinyl derivatives
US7297817B2 (en) * 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
US7423176B2 (en) * 2004-04-13 2008-09-09 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US20060024370A1 (en) * 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
WO2008077127A2 (en) * 2006-12-19 2008-06-26 Lavin Thomas N Use of modafinil to treat restless leg syndrome
US20090325999A1 (en) * 2008-06-27 2009-12-31 Jie Du Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
EP2238973A1 (en) 2009-04-07 2010-10-13 Cephalon France Lyophilized preparations of proteasome inhibitors
JP6435333B2 (ja) 2013-08-30 2018-12-05 グリーン クロス ウェルビーイング コーポレーションＧｒｅｅｎ Ｃｒｏｓｓ Ｗｅｌｌｂｅｉｎｇ Ｃｏｒｐｏｒａｔｉｏｎ ジンセノサイド成分が増加した加工人参粉末または加工人参抽出物を含有する癌関連疲労の予防及び治療用組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520812A (en) * 1975-10-02 1978-08-09 Lafon Labor Benzhydrylsulphinyl derivatives
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ＡＲＺＮＥＩＭ．−ＦＯＲＳＣＨ．／ＤＲＵＧＲＥＳ．第３９巻１０号第１２６８−１２７３頁（１９８９）

Also Published As

Publication number Publication date
JPH04230214A (ja) 1992-08-19
US5180745A (en) 1993-01-19
EP0462004B1 (fr) 1995-09-06
DE69112717T2 (de) 1996-04-11
DE69112717D1 (de) 1995-10-12
AU655769B2 (en) 1995-01-12
HK1007415A1 (en) 1999-04-09
EP0462004A3 (en) 1992-01-22
KR100190454B1 (ko) 1999-06-01
TW206916B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-06-01
HU911968D0 (en) 1991-12-30
FR2663225B1 (fr) 1994-11-04
FR2663225A1 (fr) 1991-12-20
HUT57984A (en) 1992-01-28
EP0462004A2 (fr) 1991-12-18
KR920000315A (ko) 1992-01-29
DK0462004T3 (da) 1995-10-16
HU215590B (hu) 1999-01-28
ATE127341T1 (de) 1995-09-15
AU7843691A (en) 1991-12-19

Similar Documents

Publication Publication Date Title
JP2531868B2 (ja) モダフィニルの新規使用
HK1007415B (en) New use of modafinil
Giovannitti Jr et al. Pharmacology of local anesthetics used in oral surgery
Markou et al. The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat
JP4850880B2 (ja) 疼痛の処置のためのエピナスチンの使用
Elkhawad et al. Studies on the behavioural pharmacology of a cyclic analogue of dopamine following its injection into the brains of conscious rats
WO2018068670A1 (zh) 神经兴奋性损伤相关多肽在预防、缓解或治疗疼痛的用途
JPS61145121A (ja) ジペプタイド誘導体を含有する、筋萎縮性側索硬化症を治療するための薬剤
Nishizawa et al. Tissue blood flow reductions induced by remifentanil in rabbits and the effect of naloxone and phentolamine on these changes
JPH0232023A (ja) パーキンソン症候群の治療用薬剤
Sandyk et al. Weak electromagnetic fields attenuate tremor in multiple sclerosis
Goold Postoperative spasticity and shivering: a review with personal observations of 500 patients
US20210322510A1 (en) Oxytocin improves treatment of obstructive sleep apnea
JPH01261334A (ja) アンギオテンシン転換酵素阻害剤を有効成分とした医療用調剤及びその製造方法
Barbieri et al. Effect of fenfluramine on prolactin secretion in obese patients: evidence for serotoninergic regulation of prolactin in man
CN107638391B (zh) 一种注射用苯磺顺阿曲库铵组合物
JP2519148B2 (ja) うつ病治療剤
Thomas et al. Cardiac arrhythmia during outpatient dental anaesthesia: the advantages of a controlled ventilation technique
Blackwell et al. Antidepressant drugs
Baxter Post-traumatic superior laryngeal neuralgia
Sukariada et al. The Effectivity of Ethanol Extract of Datura Metel L. Seeds as a General Anaesthesia on Kintamani Dogs
JP2002531417A (ja) 追加的な局所麻酔薬を含むパーキンソン病の症候を処置する薬剤
Hassel Improvement of muscle function in Charcot‐Marie‐Tooth disease by transcutaneous electric nerve stimulation
Mishra et al. A clinical comparison between bupivacaine midazolam combination and bupivacaine plain in brachial plexus block by supraclavicular approach
Robuschi et al. Prevention of fog-induced bronchospasm by high doses of ipratropium bromide in asthmatics

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080627

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090627

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100627

Year of fee payment: 14

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100627

Year of fee payment: 14

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110627

Year of fee payment: 15

EXPY Cancellation because of completion of term